Earli's Vision for Revolutionizing Cancer Detection
SHARON SIM • January 30, 2025

Earli is transforming early cancer detection and treatment by bioengineering cancer cells to reveal and destroy themselves. Developed at the intersection of biology, engineering, and software, this platform answers the critical question — “Is it cancer? Y/N” — while enabling targeted therapeutic applications, paving the way for a new era in cancer care.
Earli’s innovative work was recently featured in Medical Newspaper (Bosa), where CEO Cyriac Roeding shared insights on Korea and Japan’s leadership in early detection. Their groundbreaking advancements continue to push the field forward, an effort SKC is proud to support.
Read more: Full Article on Bosa
Latest Blogs

By SHARON SIM
•
December 10, 2025
Breaking into U.S. media isn’t just about showing up, it’s about playing by the rules of a new playground. At SKC, we help Asian brands turn strategy, storytelling, and timing into coverage that sticks. With the right partner, clear expectations, and cultural insight, your pitches don’t just get seen, they earn real tr

By SHARON SIM
•
November 26, 2025
When it comes to PR, having an agency isn’t enough, having a true partner is what moves the ball. At SKC, we help brands turn collaboration into momentum, aligning strategy, storytelling, and execution so every play pushes you closer to the goal. With the right game plan, clear communication, and a team working in sync

By SHARON SIM
•
October 7, 2025
When brands expand globally, showing up isn’t enough, showing up ready is what sets you apart. At SKC, we help Asian companies enter the U.S. market with confidence, crafting stories that resonate, strategies that evolve, and communications that truly connect, turning market entry into meaningful momentum.







